Hence, we suggest a high dose of rifampicin is associated with alterations in the cytokine (IL-17A, IL-6, IL-10, and IL-12) levels and could possibly,\ modulate the inflammatory mediated immune responses in TB, and might also act as a marker (IL-12, IL-6, and IL-10) of treatment outcome. This evidence concerns the gene IL6 and tuberculosis.